Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Explore this paper's citation graph
Summary
Strong recommendations apply to most patients, whereas weak recommendations are sensitive to differences among patients, including their preferences.
- Type
- article
- Published
- 2012-02-01
- Cited by
- 5,494
- References
- 551
- Access
- Open access
- OpenAlex
- https://openalex.org/W2131099415
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:1494359
Keywords
Antithrombotic, Medicine, Disease, Intensive care medicine, Internal medicine
References
- Controlled Trial of Aspirin in Cerebral Ischemia. Part II: Surgical Group
- Rapid thrombolysis and preservation of valvular venous function in high deep vein thrombosis. A comparative study between streptokinase and heparin therapy.
- Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis.
- Intermittent compression units for severe post-phlebitic syndrome: a randomized crossover study.
- Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trial
- Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis.
- Prognostic factors for pulmonary embolism: the prep study, a prospective multicenter cohort study.
- Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
- Subcutaneous Low-Molecular-Weight Heparin Fragmin Versus Intravenous Unfractionated Heparin in the Treatment of Acute Non Massive Pulmonary Embolism: An Open Randomized Pilot Study
- Comparison of Outcomes after Hospitalization for Deep Venous Thrombosis or Pulmonary Embolism
- A Double Blind Three Center Clinical Trial on the Short-Term Efficacy of 0-(β-Hydroxyethyl)-Rutosides in Patients with Post-Thrombotic Syndrome
- Optimal Duration of Oral Anticoagulant Therapy: A Randomized Trial Comparing Four Weeks with Three Months of Warfarin in Patients with Proximal Deep Vein Thrombosis
- Bed Rest in Deep Vein Thrombosis and the Incidence of Scintigraphic Pulmonary Embolism
- Low Molecular Weight Heparin versus Warfarin in the Prevention of Recurrences after Deep Vein Thrombosis
- Comparison of Once-Daily Subcutaneous Fragmin® with Continuous Intravenous Unfractionated Heparin in the Treatment of Deep Vein Thrombosis
- The Risk of Recurrent Venous Thromboembolism in Patients with and without Factor V Leiden
- Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
- Assessment of a Bleeding Risk Index in Two Cohorts of Patients Treated with Oral Anticoagulants
- High vs. low doses of low‐molecular‐weight heparin for the treatment of superficial vein thrombosis of the legs: a double‐blind, randomized trial
- Long-term results of treatment for axillary subclavian vein thrombosis.
Cited by
- Antithrombotic therapies: anticoagulation and thrombolysis.
- Foramen ovale perméable et ischémie aiguë de membre. À propos d’un cas
- [Pulmonary embolism and pregnancy].
- Stress ulcer prophylaxis, thromboprophylaxis and coagulation management in patients with hip fractures
- Pulmonary embolism: risk assessment and management.
- New anticoagulants for treatment of venous thromboembolism.
- Optimizing drug therapy in the surgical intensive care unit.
- Venous thromboembolism in cirrhosis: a review of the literature.
- Venous thromboembolism in cancer clinical trials: recommendation for standardized reporting and analysis
- Anticoagulant choices in pregnant women with mechanical heart valves: balancing maternal and fetal risks--the difference the dose makes.
- Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
- Role of the new oral anticoagulants in treatment of venous throboembolism
- A Clinician's Guide to the ABCs of Cardiovascular Disease Prevention: The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease and American College of Cardiology Cardiosource Approach to the Million Hearts Initiative
- Optimizing the Use of Anticoagulants (Heparins and Oral Anticoagulants) in the Elderly
- Vena cava filters for management of venous thromboembolism: a clinical review.
- Venous thrombosis: who should be screened for thrombophilia in 2014?
- Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?
- Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review
- Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
- Intracardiac Thrombosis after Emergent Prothrombin Complex Concentrate Administration for Warfarin Reversal.
Related papers
- ФОРМИРОВAНИЕ ГОТОВНОСТИ БУДУЩИХ ПЕДAГОГОВ К ОРГAНИЗAЦИИ РAБОТЫ ПО РAЗВИТИЮ ВAЛЕОЛОГИЧЕСКОЙ КУЛЬТУРЫ ШКОЛЬНИКОВ
- चितलवाना पंचायत समिति में मानव गरीबी सूचकांक - 2016 ( à¤à¤• गà¥à¤°à¤¾à¤® सà¥à¤¤à¤°à¥€à¤¯ à¤à¥Œà¤—ोलिक अधà¥à¤¯à¤¯à¤¨ )
- DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION
- A GEOMETRIC MEAN IN THE FURUTA INEQUALITY